Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 11:35:45 2024-06-28 EDT			5-day change	1st Jan Change
26.38 ^EUR	+1.03%		+1.46%	-21.56%

06-28	Borse Frankfurt-News: Uncertainty ahead of French election (Bond Trading)	DP
06-27	Chemicals collective agreement: Bonus days for union members	DP

Chemicals collective bargaining agreement: extra day for trade unionists

June 27, 2024 at 07:52 am

BAD BREISIG (dpa-AFX) - In the wage negotiations for the German chemical industry, IG BCE and employers have agreed an additional day off for union members only. This is the first time that exclusive benefits have been stipulated in a large collective agreement in addition to the general salary increases of 6.85 percent in Bad Breisig on the Rhine on Thursday./ceb/DP/jha

Go to the original article.
Legal disclaimer

Stocks mentioned in the article

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
MERCK KGAA	154.8 EUR	-0.51%	-7.20%	72.09B
BASF SE	45.18 EUR	-0.35%	+0.08%	43.21B
BAYER AG	26.38 EUR	+1.03%	+1.46%	27.77B
LANXESS AG	22.98 EUR	+1.06%	+5.27%	2.13B
EVONIK INDUSTRIES AG	19.05 EUR	-1.27%	+0.45%	9.51B

Latest news about Bayer AG

Borse Frankfurt-News: Uncertainty ahead of French election (Bond Trading)	06-28	DP
Chemicals collective agreement: Bonus days for union members	06-27	DP
German chemical sector employers, union agree 6.85% pay hike over 20 months	06-27	RE
Chemicals collective bargaining agreement: extra day for trade unionists	06-27	DP
The same old winners	06-27
Bayer's pharmaceuticals division plans to cut further managerial jobs	06-27	RE
Bayer's Pharmaceuticals Unit to Cut More Managerial Jobs Amid Reorganization	06-27	MT
Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia	06-26	RE
Global markets live: Bayer, FedEx, Nvidia, KKR, Verizon...	06-26
Dpa-AFX Overview: COMPANIES from 26.06.2024 - 15:15	06-26	DP
Anton switch to Dortmund perfect? Voller rows back	06-26	DP
Bayer CEO - Making faster progress with restructuring	06-26	RE
Chemical industry wage partners seek solution before the end of the peace period	06-25	DP
Bayer: patients recruited for phase 2 Parkinson's trial	06-25	CF
Bayer and Solynta Collaborate to Advance True Potato Seed in Smallholder Markets	06-23	CI
Global markets live: Vodafone, Bayer, Apple, Microsoft, Qualcomm...	06-19
Bayer's Crop Science Business Developing AI to Kill Weeds	06-19	MT
Bayer looks to AI to combat herbicide resistance faster	06-18	RE
Transcript : Bayer Aktiengesellschaft - Special Call	06-18
New Bayer short corn variety stands up to high winds, but not over 100 mph	06-18	RE
South Africa finds high prices, lack of competition in its fresh produce market	06-18	RE
Economics Minister Habeck travels to China without prominent company representatives	06-18	RE
Alvotech Enters Commercialization Deal for Eylea Biosimilars with Advanz Pharma	06-18	MT
Nationwide actions - Trade union increases pressure in chemical industry collective bargaining round	06-18	DP
German economy minister's China trip features low-key business delegation amid EV clash	06-18	RE

Chart Bayer AG

Duration

Period

More charts

Company Profile

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).

Sector

Pharmaceuticals

Calendar

2024-08-06 - Q2 2024 Earnings Release

Related indices

Euro STOXX 50 Index , STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

BAYER : As soft as anticipated

May 14, 2024 at 02:12 pm

Bayer AG: Not out of the woods yet

March 06, 2024 at 10:46 am

More Strategies

Ratings for Bayer AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

26.38 EUR

Average target price

36.18 EUR

Spread / Average Target

+37.16%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BAYER AG	-21.56%	27.77B
ELI LILLY AND COMPANY	+55.32%	815B
NOVO NORDISK A/S	+44.05%	641B
JOHNSON & JOHNSON	-6.75%	352B
MERCK & CO., INC.	+13.56%	314B
ABBVIE INC.	+10.68%	303B
ASTRAZENECA PLC	+16.57%	242B
NOVARTIS AG	+13.31%	218B
AMGEN INC.	+8.48%	168B
PFIZER, INC.	-2.81%	159B

Other Pharmaceuticals

Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Chemicals collective bargaining agreement: extra day for trade unionists

Stocks mentioned in the article

EPS Revisions